Article Text

PDF
The cystic fibrosis transmembrane conductance regulator (Cftr) modulates the timing of puberty in mice
  1. R Jin1,2,3,
  2. C A Hodges1,
  3. M L Drumm1,2,
  4. M R Palmert1,2
  1. 1Department of Pediatrics, Case Western Reserve School of Medicine and Rainbow Babies and Children’s Hospital, University Hospitals of Cleveland, Cleveland, OH 44106, USA
  2. 2Department of Genetics, Case Western Reserve University School of Medicine, Cleveland, OH 44106, USA
  3. 3Department of Biology, Case Western Reserve University, Cleveland, OH 44106, USA
  1. Correspondence to:
 Dr Mark R Palmert
 Division of Pediatric Endocrinology and Metabolism, Rainbow Babies and Children’s Hospital, University Hospitals of Cleveland, 11100 Euclid Avenue, Cleveland, OH 44106, USA; mark.palmert{at}case.edu

Abstract

Background: Delayed puberty is common among individuals with cystic fibrosis (CF) and is usually attributed to chronic disease and/or poor nutrition. However, it has recently been recognised that pubertal delay can occur even in the setting of good nutritional and clinical status. This finding, along with evidence that Cftr is expressed in rat brain, human hypothalamus, and a gonadotropin releasing hormone secreting cell line, raises the possibility that some of the pubertal delay in CF could stem directly from alterations in Cftr function that affect the hypothalamic-pituitary-gonadal axis.

Methods: To examine this hypothesis, we investigated pubertal timing (as assessed by vaginal opening (VO)) in a mouse model of CF (Cftrtm1Unc) engineered to produce a truncated Cftr mRNA and referred to as S489X. Homozygous knockout, heterozygote, and wild type (WT) female mice were examined.

Results: As expected, the S489X/S489X knockout mice, which have chronic inflammation and gastrointestinal disease, grew more slowly and had later onset of puberty than WT animals. We anticipated that the S489X/S489X+ heterozygotes, which have no clinical CF phenotype, might display an intermediate timing of puberty. Surprisingly, however, these mice had earlier VO than WT. These findings were confirmed in a second, independent model of CF engineered to generate the ΔF508 mutation in mice. Again, the homozygotes displayed later pubertal timing, while the heterozygotes displayed earlier VO than the WT animals.

Conclusions: These data provide further evidence that Cftr can directly modulate the reproductive endocrine axis and raise the possibility that heterozygate mutation carriers may have a reproductive advantage.

  • CF, cystic fibrosis
  • GnRH, gonadotropoin releasing hormone
  • HPG axis, hypothalamic-pituitary-gonadal axis
  • VO, vaginal opening
  • WT, wild type
  • cystic fibrosis
  • delayed puberty
  • GnRH
  • gonadotropin releasing hormone

Statistics from Altmetric.com

Footnotes

  • This work was supported by NIH grants K23 RR15544 (MRP) and HL68883 (MLD)

  • Competing interests: none declared

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.